Premium
Bullous pemphigoid induced by pembrolizumab in a patient with non‐small‐cell lung cancer who achieved durable complete response despite treatment cessation and long‐term corticosteroid administration: A case report
Author(s) -
Muto Yusuke,
Namikawa Kenjiro,
Fujiwara Yutaka,
Mori Taisuke,
Nakano Eiji,
Takahashi Akira,
Yamazaki Naoya
Publication year - 2020
Publication title -
the journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.9
H-Index - 65
eISSN - 1346-8138
pISSN - 0385-2407
DOI - 10.1111/1346-8138.15140
Subject(s) - pembrolizumab , medicine , lung cancer , dermatology , bullous pemphigoid , administration (probate law) , corticosteroid , term (time) , cancer , pemphigoid , oncology , immunotherapy , immunology , antibody , quantum mechanics , political science , law , physics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom